New study reveals what kinds of patents win at IPR. It’s good news for biotech, bad news for semiconductors
Register to access two of our subscriber only articles per month.
Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.
Author | Data Reporter
@IAM_magazine DuPont IP deal with Chinese company nets over $500,000 per patent family, with potential for royalties to follow… https://t.co/iPLbtQ4fZN Read more
@IAM_magazine "Patent sales are now an integral part of our innovation cycle," says IBM's global IP head William Fontaine in an e… https://t.co/GTc1tTPpOr Read more
@IAM_magazine Join our upcoming webinar hosted by @Patentship on 3 November at 2 GMT where Robert Klinski will be discussing how… https://t.co/nstEKXTv6j Read more
@IAM_magazine RT @UNHLaw: Dean @megancarpenter in @IAM_magazine, "We have a real opportunity, however, to create a new normal in professional graduate ed… Read more